Indapamide Biogaran

Indapamide, the active ingredient in Indapamide Biogaran, is a thiazide‑like diuretic presented as an oral tablet for adult use. It is employed to lower elevated blood pressure and to reduce fluid accumulation in patients with heart‑failure‑related edema and improve cardiovascular outcomes under medical supervision.

GNH USA supplies Indapamide Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our global distribution network ensures reliable delivery and regulatory compliance for all qualified healthcare partners. We adhere to stringent quality standards and provide comprehensive documentation to support import and pharmacovigilance requirements. Our team is available to assist with technical queries and post‑market support.

Indapamide acts on the renal tubular system to manage conditions characterized by elevated blood pressure or fluid overload.

Hypertension: reduces systolic and diastolic blood pressure, improving cardiovascular risk profile. Edema associated with heart failure: promotes sodium and water excretion, decreasing peripheral fluid accumulation. Fluid retention in renal or hepatic disease: facilitates diuresis to alleviate swelling.

Indapamide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urinary frequency - Electrolyte imbalance, especially low potassium - Nausea or abdominal discomfort

Serious or Rare Side Effects: - Severe dehydration or electrolyte disturbances (e.g., hyponatremia) - Acute kidney injury - Severe allergic reactions such as Stevens‑Johnson syndrome - Gout attacks due to uric acid elevation - Blood dyscrasias (e.g., agranulocytosis)

When prescribing Indapamide, clinicians should consider several safety measures to minimize risk.

Monitor electrolytes: regular blood tests to detect sodium, potassium and uric acid changes. Assess renal function: evaluate creatinine clearance before initiation and during therapy. Use caution in elderly: increased susceptibility to volume depletion and orthostatic hypotension. Avoid concurrent lithium therapy: risk of lithium toxicity may be heightened. Adjust dose in hepatic impairment: reduced clearance may require dose modification. Store at below 25°C: keep in the original pack, protect from moisture.

Indapamide can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity. - Digoxin: enhanced digoxin levels may lead to toxicity. - Cyclosporine: may amplify nephrotoxic effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive blood‑pressure lowering effect. - NSAIDs: may reduce diuretic efficacy and impair renal function. - Beta‑blockers: potential for excessive hypotension. - Antidiabetic sulfonylureas: may enhance hypoglycemic effect.